Stock TWST TWIST BIOSCIENCE CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

News Twist Bioscience Corporation

Equities

TWST

US90184D1000

Market Closed - Nasdaq
Other stock markets
 04:00:03 2024-05-31 pm EDT 		5-day change 1st Jan Change
41.88 USD +2.57% Intraday chart for Twist Bioscience Corporation -0.83% +13.62%
May. 22 Oxford Nanopore Technologies Collaborates with Twist Bioscience to Launch Pharmacogenomics Beta Programme and Advance Personalised Medicine CI
May. 13 Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-Throughput Screening Applications CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Twist Bioscience to Present at Upcoming Investor Conferences
BU
Oxford Nanopore Technologies Collaborates with Twist Bioscience to Launch Pharmacogenomics Beta Programme and Advance Personalised Medicine
CI
Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications
BU
Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-Throughput Screening Applications
CI
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(4)
AQ
Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
BU
Sector Update: Health Care Stocks Mixed Late Afternoon
MT
Sector Update: Health Care Stocks Mixed in Afternoon Trading
MT
Twist Bioscience Shares Jump After Fiscal Q2 Beat, Fiscal 2024 Revenue Guidance Raised
MT
Twist Bioscience : Fiscal 2024 2Q Financial Results
PU
Twist Bioscience: Fiscal Q2 Earnings Snapshot
AQ
Transcript : Twist Bioscience Corporation, Q2 2024 Earnings Call, May 02, 2024
Earnings Flash (TWST) TWIST BIOSCIENCE CORPORATION Posts Q2 Revenue $75.3M, vs. Street Est of $70.8M
MT
Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results
BU
Twist Bioscience Corporation Revises Earnings Guidance for the Fiscal Year 2024
CI
Twist Bioscience Corporation Provides Earnings Guidance for the Third Quarter and Fourth Quarter of Fiscal Year 2024
CI
Twist Bioscience Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024
CI
Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
BU
Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations
BU
Twist Bioscience Corporation Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TWST Stock
  4. News Twist Bioscience Corporation